Gestion des effets secondaires de la suppression androgénique.
Auteurs : Lebret T1, Méjean AAffiliations : 1Service d'Urologie, Hôpital Foch, Faculté de médecine Paris-Ile-de-France-Ouest, UVSQ, France.
Date 2008 Novembre, Vol 18 Suppl 7, pp S338-42Revue : Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologieType de publication : article de périodique; DOI : 10.1016/S1166-7087(08)74564-0Résumé
Androgeno-deprivation is the treatment of reference for metastatic prostate cancer but it generates side effects which are too often ignored by physicians due to concentration on hopes of carcinologic benefit. Hot flashes, metabolic syndrome (body mass and lipid changes), decreased libido, erectile dysfunction, anemia, cognitive dysfunction, gynecomastia, decreased muscular mass and osteoporosis are the most frequent symptoms. They can and must be prevented by advice on physical activity and nutrition.